Literature DB >> 24731997

Prostate cancer: validated tool predicts survival of men taking abiraterone after docetaxel.

Sarah Payton.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24731997     DOI： 10.1038/nrurol.2014.85

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  External validation of a prognostic model predicting overall survival in metastatic castrate-resistant prostate cancer patients treated with abiraterone.

Authors:  Praful Ravi; Joaquin Mateo; David Lorente; Zafeiris Zafeiriou; Amelia Altavilla; Roberta Ferraldeschi; Spyridon Sideris; Emily Grist; Alan Smith; Sophia Wong; Diletta Bianchini; Gerhardt Attard; Johann S de Bono
Journal:  Eur Urol       Date:  2014-03-26       Impact factor: 20.096
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.